Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A

NCT02971930 · clinicaltrials.gov ↗
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer